YAG
RDHL

Yorkville Advisors Global’s Redhill Biopharma RDHL Stock Holding History

Yorkville Advisors Global’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Sell
122,131
-228,739
-65% -$211K 0.12% 31
2026
Q1 		$261K Sell
350,870
-35,723
-9% -$37.6K 0.17% 29
2025
Q4 		$398K Buy
+386,593
New +$520K 0.25% 20

Other funds holding RDHL

GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return

Yorkville Advisors Global's RDHL Position: Q2 2026 in Review

Yorkville Advisors Global reduced its Redhill Biopharma (RDHL) stake by 65% in Q2 2026, selling an estimated $211K and leaving 122,131 shares worth $107K. The position accounts for 0.12% of the portfolio, ranked #31.

Yorkville Advisors Global first reported a position in RDHL in Q4 2025 and has held it in 3 quarters since. The position peaked at $398K in Q4 2025. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • Yorkville Advisors Global held 122,131 shares of Redhill Biopharma worth $107K as of Q2 2026.
  • Yorkville Advisors Global sold 228,739 Redhill Biopharma shares in Q2 2026, an estimated $211K.
  • Redhill Biopharma made up 0.12% of Yorkville Advisors Global's portfolio in Q2 2026, its #31 holding.
  • Yorkville Advisors Global first reported a position in Redhill Biopharma in Q4 2025 and has held it in 3 quarters since.
  • Yorkville Advisors Global's Redhill Biopharma position peaked at $398K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on Yorkville Advisors Global's 13F filing for Q2 2026, filed 6 Aug 2026.